» Articles » PMID: 15373904

Microarray Analysis of Human Milk Cells: Persistent High Expression of Osteopontin During the Lactation Period

Overview
Date 2004 Sep 18
PMID 15373904
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

To continue the search for immunological roles of breast milk, cDNA microarray analysis on cytokines and growth factors was performed for human milk cells. Among the 240 cytokine-related genes, osteopontin (OPN) gene ranked top of the expression. Real-time PCR revealed that the OPN mRNA levels in colostrum cells were approximately 100 times higher than those in PHA-stimulated peripheral blood mononuclear cells (PBMNCs), and 10 000 times higher than those in PB CD14(+) cells. The median levels of OPN mRNA in early milk or mature milk cells were more than three times higher than those in colostrum cells. Western blot analysis of human milk showed appreciable expression of full-length and short form proteins of OPN. The concentrations of full-length OPN in early milk or mature milk whey continued to be higher than those in colostrum whey and plasma as assessed by ELISA. The early milk (3-7 days postpartum) contained the highest concentrations of OPN protein, while the late mature milk cells (1 years postpartum) had the highest expression of OPN mRNA of all the lactating periods. The results of immunohistochemical and immunocytochemical staining indicated that OPN-producing epithelial cells and macrophages are found in actively lactating mammary glands. These results suggest that the persistently and extraordinarily high expression of OPN in human milk cells plays a potential role in the immunological development of breast-fed infants.

Citing Articles

Matrix Background Screening of an ssDNA Aptamer and Its Identification Against Lactopontin.

Zhu C, Feng Z, Yan M, Du H, Li T, Mao J Int J Mol Sci. 2024; 25(21).

PMID: 39519381 PMC: 11546233. DOI: 10.3390/ijms252111832.


An expert panel on the adequacy of safety data and physiological roles of dietary bovine osteopontin in infancy.

Fleming S, Reyes S, Donovan S, Hernell O, Jiang R, Lonnerdal B Front Nutr. 2024; 11:1404303.

PMID: 38919388 PMC: 11197938. DOI: 10.3389/fnut.2024.1404303.


Analytical Ultracentrifugation-Calibrated Anion-Exchange Chromatography for Sensitive and Intact Determination of Osteopontin in Infant Formula and Dairy Products.

Wang X, Cui D, Qu X, You H, Lei F, Li J J Agric Food Chem. 2023; 71(37):13880-13888.

PMID: 37669461 PMC: 10515612. DOI: 10.1021/acs.jafc.3c03589.


Milk Osteopontin and Human Health.

Sorensen E, Christensen B Nutrients. 2023; 15(11).

PMID: 37299387 PMC: 10255459. DOI: 10.3390/nu15112423.


Longitudinal changes of lactopontin (milk osteopontin) in term and preterm human milk.

Zhu J, Yu X, Wang Y, Bai S, Lai J, Tong X Front Nutr. 2022; 9:962802.

PMID: 35967792 PMC: 9372532. DOI: 10.3389/fnut.2022.962802.


References
1.
Bernt K, Walker W . Human milk as a carrier of biochemical messages. Acta Paediatr Suppl. 1999; 88(430):27-41. DOI: 10.1111/j.1651-2227.1999.tb01298.x. View

2.
Shibakura M, Niiya K, Kiguchi T, Kitajima I, Niiya M, Asaumi N . Induction of IL-8 and monoclyte chemoattractant protein-1 by doxorubicin in human small cell lung carcinoma cells. Int J Cancer. 2002; 103(3):380-6. DOI: 10.1002/ijc.10842. View

3.
Nemir M, Bhattacharyya D, Li X, Singh K, Mukherjee A, Mukherjee B . Targeted inhibition of osteopontin expression in the mammary gland causes abnormal morphogenesis and lactation deficiency. J Biol Chem. 2000; 275(2):969-76. DOI: 10.1074/jbc.275.2.969. View

4.
Ashkar S, Weber G, Panoutsakopoulou V, Sanchirico M, Jansson M, Zawaideh S . Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science. 2000; 287(5454):860-4. DOI: 10.1126/science.287.5454.860. View

5.
Bottcher M, Jenmalm M, Bjorksten B, Garofalo R . Chemoattractant factors in breast milk from allergic and nonallergic mothers. Pediatr Res. 2000; 47(5):592-7. DOI: 10.1203/00006450-200005000-00006. View